Shihab, Uddin

PhD in Biological/biomedical sciences, Senior lecturer, Associate member of the Bangladesh Academy of Sciences
🥼
🤝
Publications
20
Citations
421
h-index
10

About

Dr. Shihab Uddin, assistant professor of the bioengineering department at KFUPM, is an enthusiastic multidisciplinary educator who actively supervises and instructs graduate and undergraduate students in these fields.  He is a highly motivated research scientist with a track record of success in academia & industry and has experience working with scientists from diverse backgrounds around the world. He has personal expertise dealing with animal models, computational chemistry, and wet chemistry. He conducted extensive research in the domains of synthetic chemistry, biomaterials, nanotechnology, drug design, formulations & delivery (peptide, protein, & mRNA), immunotherapy, pharmacokinetics, pharmacodynamics, analytical method development & validation of different pharmaceutical products (liquids, solids, and volatile formulations), diabetics, cancer biology, and vaccination. His passion for bio-nanotechnology is evident in his youthful and enthusiastic nature as a budding researcher.

He received his PhD-Eng from Kyushu University, Japan, in 2021. Following that, he had the honour of being hired as a postdoctoral associate in the chemical engineering department at the Massachusetts Institute of Technology (MIT) and served till 2023. He also received his B.Sc. and M.Sc. majors in biochemistry and molecular biology. Following the completion of his Master's degree, he started his career as an associate scientist in the R&D department at Square Pharmaceutical Ltd.,(FDA-plant) from 2015–2018.

He was awarded the NST-BD Fellowship and MEXT-Japan Fellowship. During his PhD, he concentrated his research on synthetic chemistry and nanodrug delivery systems for cancer treatment, both in vitro and in vivo. He was subsequently employed as a postdoctoral fellow at MIT-USA, where he contributed to two state-of-the-art biomedical projects: the development of lipid nanoparticle (LNP)-based mRNA vaccines and high-concentration therapeutic antibody formulations continuous to manufacturing, funded by Takeda-USA and USFDA-USA.

Expand

Education

Massachusetts Institute of Technology
2022 — 2023, Specialist, Chemical
Kyushu University
2018 — 2022, Doctor, Interdisciplinary Graduate School of Engineering Sciences
Found 
Found 
Found 
See full statistics
Total publications
20
Total citations
421
Citations per publication
21.05
Average publications per year
2
Average coauthors
5.3
Publications years
2016-2025 (10 years)
h-index
10
i10-index
11
m-index
1
o-index
28
g-index
20
w-index
4
Metrics description

Fields of science

1
2
3
4
5
General Chemistry, 5, 25%
Biomaterials, 4, 20%
Biomedical Engineering, 4, 20%
Biochemistry (medical), 4, 20%
Drug Discovery, 2, 10%
Renewable Energy, Sustainability and the Environment, 2, 10%
Geography, Planning and Development, 2, 10%
Materials Chemistry, 1, 5%
Metals and Alloys, 1, 5%
Surfaces, Coatings and Films, 1, 5%
Ceramics and Composites, 1, 5%
Electronic, Optical and Magnetic Materials, 1, 5%
Catalysis, 1, 5%
Organic Chemistry, 1, 5%
Physical and Theoretical Chemistry, 1, 5%
Pharmaceutical Science, 1, 5%
Molecular Medicine, 1, 5%
Multidisciplinary, 1, 5%
Analytical Chemistry, 1, 5%
Chemistry (miscellaneous), 1, 5%
General Materials Science, 1, 5%
Industrial and Manufacturing Engineering, 1, 5%
Civil and Structural Engineering, 1, 5%
Management, Monitoring, Policy and Law, 1, 5%
Safety, Risk, Reliability and Quality, 1, 5%
Transportation, 1, 5%
1
2
3
4
5

Journals

1
2
3
4
1
2
3
4

Citing journals

2
4
6
8
10
12
14
16
18
20
Journal not defined, 19, 4.46%
Show all (70 more)
2
4
6
8
10
12
14
16
18
20

Publishers

1
2
3
4
5
6
7
8
1
2
3
4
5
6
7
8

Organizations from articles

1
2
3
4
5
6
7
8
Organization not defined, 5, 25%
1
2
3
4
5
6
7
8

Countries from articles

2
4
6
8
10
12
Bangladesh, 11, 55%
Japan, 8, 40%
Malaysia, 6, 30%
Country not defined, 5, 25%
USA, 5, 25%
Saudi Arabia, 2, 10%
2
4
6
8
10
12

Citing organizations

20
40
60
80
100
120
140
Organization not defined, 123, 29.22%
Show all (70 more)
20
40
60
80
100
120
140

Citing countries

10
20
30
40
50
60
70
80
90
100
China, 93, 22.09%
Country not defined, 84, 19.95%
USA, 56, 13.3%
India, 34, 8.08%
Japan, 27, 6.41%
Malaysia, 21, 4.99%
Bangladesh, 19, 4.51%
Republic of Korea, 15, 3.56%
United Kingdom, 13, 3.09%
Australia, 8, 1.9%
Italy, 8, 1.9%
Saudi Arabia, 8, 1.9%
Iran, 7, 1.66%
Germany, 6, 1.43%
France, 6, 1.43%
Portugal, 6, 1.43%
Russia, 5, 1.19%
Brazil, 5, 1.19%
Denmark, 5, 1.19%
Singapore, 5, 1.19%
Indonesia, 4, 0.95%
Canada, 4, 0.95%
Netherlands, 4, 0.95%
Norway, 4, 0.95%
Pakistan, 4, 0.95%
Mexico, 3, 0.71%
Poland, 3, 0.71%
Thailand, 3, 0.71%
Turkey, 3, 0.71%
South Africa, 3, 0.71%
Egypt, 2, 0.48%
Spain, 2, 0.48%
Qatar, 2, 0.48%
Oman, 2, 0.48%
Czech Republic, 2, 0.48%
Switzerland, 2, 0.48%
Sweden, 2, 0.48%
Sri Lanka, 2, 0.48%
Austria, 1, 0.24%
Argentina, 1, 0.24%
Bahrain, 1, 0.24%
Bulgaria, 1, 0.24%
Brunei, 1, 0.24%
Vietnam, 1, 0.24%
Greece, 1, 0.24%
Iraq, 1, 0.24%
Kuwait, 1, 0.24%
Morocco, 1, 0.24%
Nigeria, 1, 0.24%
New Zealand, 1, 0.24%
UAE, 1, 0.24%
Romania, 1, 0.24%
Sudan, 1, 0.24%
Tunisia, 1, 0.24%
Croatia, 1, 0.24%
Chile, 1, 0.24%
Show all (26 more)
10
20
30
40
50
60
70
80
90
100
  • We do not take into account publications without a DOI.
  • Statistics recalculated daily.
Position
Assistant professor
Employment type
Full time
Years
2023 — present
Position
Postdoctoral researcher
Employment type
Full time
Years
2022 — 2023
Company/Organization
Square Pharmaceuticals Limited
Position
Scientist
Employment type
Full time
Years
2015 — 2018